Shen’an Decoction Alleviates Renal Tissue Injury in Rats with Diabetic Kidney Disease by Improving Mitochondrial Homeostasis and Endoplasmic Reticulum Stress

doi:10.3870/j.issn.1672-0741.25.08.015

Abstract

Abstract: Objective To investigate whether Shen’an decoction alleviates renal injury in diabetic kidney disease(DKD)rats by improving mitochondrial homeostasis and endoplasmic reticulum stress. Methods The rat model of DKD was established.Venous blood from the tail of the rats and urine were collected at 0,2,4,and 8 weeks respectively.The fasting blood glucose content and the ratio of urinary microalbumin to urinary creatinine(ACR)were detected.The levels of renal function indicators such as serum creatinine(sCr),blood urea(BUN),and serum uric acid(UA),as well as liver function indicators such as albumin(ALB),alanine aminotransferase(ALT),and aspartate aminotransferase(AST)were detected by reagent kits.The pathological changes of rat renal tissues were observed by HE staining,PAS staining,Masson staining,and PASM staining.The ATP content,mitochondrial membrane potential(MMP),mitochondrial functional proteins(mitochondrial-related proteins cytochrome C[Cyt C],mitochondrial transcription factor A[TFAM]),and endoplasmic reticulum stress proteins(CHOP,PERK)in renal tissues were detected by using kits,flow cytometry and Western blot,and the oxidative stress levels(MDA,SOD,GSH)were evaluated. Results Compared with the normal group,the fasting blood glucose and urinary ACR of DKD rats in the model group were significantly increased at 0,2,4,and 8 weeks of drug intervention.Renal pathological staining showed that in the model group,narrowing of the glomerular lumen in the renal tissue,edema of the renal tubular epithelial cells,and infiltration of inflammatory cells could be observed,and there were thickening of the glomerular basement membrane,hyperplasia of collagen fibers and glycogen deposition in the tubular epithelium and interstitium of the kidneys,glomerular sclerosis and interstitial fibrosis.After treatment with Shen’an decoction,the above-mentioned pathological changes were significantly improved.Compared with the normal group,the ATP content and MMP expression in the renal tissues of the model group decreased,while the expression levels of Cyt C and TFAM significantly increased.After treatment with the Shen’an decoction,all the above-mentioned changes were reversed,and the pathological damage of the kidneys was significantly improved,suggesting that Shen’an decoction plays an important role in the mitochondrial ecological balance of DKD rats.In addition,the expression levels of reticulum stress-related proteins(CHOP and PERK)and the content of GSH in the renal tissues of rats in the model group were significantly higher,while the contents of MDA and SOD were significantly lower than those in the normal group.After treatment with Shen’an decoction,all the above-mentioned indicators were reversed.It indicates that Shen’an decoction alleviates renal injury by influencing endoplasmic reticulum stress in cells. Conclusion Shen’an decoction inhibits endoplasmic reticulum stress in rats with DKD and promotes mitochondrial homeostasis to alleviate renal tissue damage in rats with DKD.

Key words: diabetic kidney disease, shen’an decoction, mitochondrial homeostasis, endoplasmic reticulum stress, ATP, mitochondrial membrane potential

CLC Number:

R285.5

Huang Yeni, Xie Yu, Hu Miaoqing et al. Shen’an Decoction Alleviates Renal Tissue Injury in Rats with Diabetic Kidney Disease by Improving Mitochondrial Homeostasis and Endoplasmic Reticulum Stress[J]. Acta Medicinae Universitatis Scientiae et Technologiae Huazhong, 2026, 55(3): 354-362.

References

[1] Elendu C,John Okah M,Fiemotongha K D J,et al.Comprehensive advancements in the prevention and treatment of diabetic nephropathy:A narrative review[J].Medicine(Baltimore),2023,102(40):e35397.
[2] Li X,Lu L,Hou W,et al.Epigenetics in the pathogenesis of diabetic nephropathy[J].Acta Biochim Biophys Sin(Shanghai),2022,54(2):163-172.
[3] Dwivedi S,Sikarwar M S.Diabetic nephropathy:Pathogenesis,mechanisms,and therapeutic strategies[J].Horm Metab Res,2025,57(1):7-17.
[4] Shen S,Zhong H,Zhou X,et al.Advances in traditional chinese medicine research in diabetic kidney disease treatment[J].Pharm Biol,2024,62(1):222-232.
[5] Tang G,Li S,Zhang C,et al.Clinical efficacies,underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management[J].Acta Pharm Sin B,2021,11(9):2749-2767.
[6] 郭旭.肾安汤对糖尿病肾病脾肾阳虚证患者血清VEGF、尿KIM-1的影响[D].长沙:湖南中医药大学,2023.
Guo X.Effect of Shen’an decoction on serum VEGF and urinary KIM-1 in patients with diabetic nephropathy of spleen-kidney Yang deficiency syndrome[D].Changsha:Hunan University of Chinese Medicine,2023.
[7] Yao L,Liang X,Qiao Y,et al.Mitochondrial dysfunction in diabetic tubulopathy[J].Metabolism,2022,131:155195.
[8] Takasu M,Kishi S,Nagasu H,et al.The role of mitochondria in diabetic kidney disease and potential therapeutic targets[J].Kidney Int Rep,2024,10(2):328-342.
[9] Zhang J,Guo J,Yang N,et al.Endoplasmic reticulum stress-mediated cell death in liver injury[J].Cell Death Dis,2022,13(12):1051.
[10] Sankrityayan H,Oza M J,Kulkarni Y A,et al.ER stress response mediates diabetic microvascular complications[J].Drug Discov Today,2019,24(12):2247-2257.
[11] Liu Z,Nan P,Gong Y,et al.Endoplasmic reticulum stress-triggered ferroptosis via the XBP1-Hrd1-Nrf2 pathway induces EMT progression in diabetic nephropathy[J].Biomed Pharmacother,2023,164:114897.
[12] 郭克磊,李颖利,宣晨光,等.益气养阴化浊通络方通过调控miR-21a-5p/FoxO1/PINK1介导的线粒体自噬减轻糖尿病肾病小鼠的足细胞损伤[J].南方医科大学学报,2025,45(1):27-34.
Guo K L,Li Y L,Xuan C G,et al.Yiqi Yangyin Huazhuo Tongluo Formula alleviates diabetic podocyte injury by regulating miR-21a-5p/FoxO1/PINK1-mediated mitochondrial autophagy[J].J South Med Univ,2025,45(1):27-34.
[13] 刘雨梦,李姝玉,冯婧,等.肾气丸减轻糖尿病ZDF大鼠的肾损伤研究[J].中国比较医学杂志,2022,32(8):19-26.
Liu Y M,Li S Y,Feng J,et al.Effect of Shenqiwan in alleviating renal injury in diabetic ZDF rats[J].Chin J Comp Med,2022,32(8):19-26.
[14] Xu X,Zhou B,Liu J,et al.Ru360 alleviates postoperative cognitive dysfunction in aged mice by inhibiting MCU-mediated mitochondrial dysfunction[J].Neuropsychiatr Dis Treat,2023,19:1531-1542.
[15] Ruiz-Ortega M,Rodrigues-Diez R R,Lavoz C,et al.Special issue "diabetic nephropathy:Diagnosis,prevention and treatment"[J].J Clin Med,2020,9(3):813.
[16] Liang H,Chen S,Zhong J,et al.Dapagliflozin improves diabetic nephropathy by regulating autophagy and ferroptosis through CYP450s/ROS pathway[J].Biochem Pharmacol,2025,240:117134.
[17] Rahimi A,Nikooei S,Roozbehi K,et al.Circulating levels of miR-155 and CTBP1-AS2 as a promising biomarker for early detection of diabetic nephropathy[J].Biochem Genet,2025.doi:10.1007/s10528-025-11176-2.
[18] Liu X J,Hu X K,Yang H,et al.A review of traditional chinese medicine on treatment of diabetic nephropathy and the involved mechanisms[J].Am J Chin Med,2022,50(7):1739-1779.
[19] 胡淑娟,李旭华,刘秀,等.左归降糖益肾方调控miRNA-27a/Wnt/β-catenin通路对糖尿病肾病大鼠的影响及机制[J].中国实验方剂学杂志,2024,30(19):90-97.
Hu S J,Li X H,Liu X,et al.Effect and mechanism of Zuogui Jiangtang Yishen prescription on diabetic nephropathy rats by regulating miRNA-27a/Wnt/β-catenin pathway[J].Chin J Exp Tradit Med Form,2024,30(19):90-97.
[20] Deng Y,Zhong G,Jin T,et al.Mechanism exploration of Wenshen Jianpi Decoction on renoprotection in diabetic nephropathy via transcriptomics and metabolomics[J].Phytomedicine,2025,139:156446.
[21] Mohammad H M F,Galal Gouda S,Eladl M A,et al.Metformin suppresses LRG1 and TGFβ1/ALK1-induced angiogenesis and protects against ultrastructural changes in rat diabetic nephropathy[J].Biomed Pharmacother,2023,158:114128.
[22] Guo M,Gao J,Jiang L,et al.Astragalus polysaccharide ameliorates renal inflammatory responses in a diabetic nephropathy by suppressing the TLR4/NF-κB pathway[J].Drug Des Devel Ther,2023,17:2107-2118.
[23] Yu R,Wu R,Chen T,et al.Yiqi yangyin tongluo recipe alleviates diabetic kidney disease through AGE-RAGE signalling axis[J].Diabetes Metab Syndr Obes,2025,18:2041-2055.
[24] Xiong W,Feng J,Liu Y,et al.ShenQiWan ameliorates renal injury in type 2 diabetic mice by modulating mitochondrial fusion and endoplasmic reticulum stress[J].Front Pharmacol,2023,14:1265551.
[25] Rosselin M,Santo-Domingo J,Bermont F,et al.L-OPA1 regulates mitoflash biogenesis independently from membrane fusion[J].EMBO Rep,2017,18(3):451-463.
[26] Chen H,Zhang H,Li A M,et al.VDR regulates mitochondrial function as a protective mechanism against renal tubular cell injury in diabetic rats[J].Redox Biol,2024,70:103062.
[27] Rizk F H,El Saadany A A,Atef M M,et al.Ulinastatin ameliorated streptozotocin-induced diabetic nephropathy:Potential effects via modulating the components of gut-kidney axis and restoring mitochondrial homeostasis[J].Pflugers Arch,2023,475(10):1161-1176.
[28] Shu C W,Sun F C,Cho J H,et al.GRP78 and Raf-1 cooperatively confer resistance to endoplasmic reticulum stress-induced apoptosis[J].J Cell Physiol,2008,215(3):627-635.
[29] Xiong S,Han Y,Gao P,et al.AdipoRon protects against tubular injury in diabetic nephropathy by inhibiting endoplasmic reticulum stress[J].Oxid Med Cell Longev,2020,2020:6104375.
[30] 何亚萍,贾登科,陈文英,等.基于线粒体自噬探讨中医药干预糖尿病肾病的研究进展[J].中医药信息,2024,41(11):72-78.
He Y P,Jia D K,Chen W Y,et al.Research progress on traditional Chinese medicine intervention in diabetic nephropathy based on mitophagy[J].Inf Tradit Chin Med,2024,41(11):72-78.
[31] Beaulant A,Dia M,Pillot B,et al.Endoplasmic reticulum-mitochondria miscommunication is an early and causal trigger of hepatic insulin resistance and steatosis[J].J Hepatol,2022,77(3):710-722.